Sarepta Therapeutics Inc (SRPT.OQ)

SRPT.OQ on NASDAQ Stock Exchange Global Select Market

13.28USD
31 Mar 2015
Change (% chg)

$-0.59 (-4.25%)
Prev Close
$13.87
Open
$13.70
Day's High
$13.92
Day's Low
$13.15
Volume
136,550
Avg. Vol
222,789
52-wk High
$40.00
52-wk Low
$11.34

SRPT.OQ

Chart for SRPT.OQ

About

Sarepta Therapeutics Inc. (Sarepta), formerly AVI BioPharma, Inc., is a biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases. The Company has classified its drug development programs as Duchenne Muscular Dystrophy (DMD)... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $572.99
Shares Outstanding(Mil.): 41.31
Dividend: --
Yield (%): --

Financials

  SRPT.OQ Industry Sector
P/E (TTM): -- 136.15 41.01
EPS (TTM): -3.38 -- --
ROI: -52.86 -0.91 16.17
ROE: -54.88 -2.73 17.02
Search Stocks

Sarepta drug protects lab monkeys from Ebola

NEW YORK - An experimental Ebola drug from Sarepta Therapeutics Inc protected six of eight lab monkeys injected with the virus, scientists from the company and the U.S. Army reported on Tuesday.

10 Feb 2015

UPDATE 1-Sarepta drug protects lab monkeys from Ebola

NEW YORK, Feb 10 - An experimental Ebola drug from Sarepta Therapeutics Inc protected six of eight lab monkeys injected with the virus, scientists from the company and the U.S. Army reported on Tuesday.

10 Feb 2015

UPDATE 2-BioMarin buys Prosensa for muscle wasting disorder drug

Nov 24 - BioMarin Pharmaceuticals Inc said it would buy Dutch drug developer Prosensa Holding NV for about $840 million, betting on a drug that has potential to become the first approved treatment for a rare muscle disorder.

24 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks